These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7448410)

  • 1. The chemotherapy of lymphoblastic lymphoma.
    Voakes JB; Jones SE; McKelvey EM
    Blood; 1981 Jan; 57(1):186-8. PubMed ID: 7448410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
    Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
    Levine AM; Forman SJ; Meyer PR; Koehler SC; Liebman H; Paganini-Hill A; Pockros A; Lukes RJ; Feinstein DI
    Blood; 1983 Jan; 61(1):92-8. PubMed ID: 6600214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
    Case DC
    Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study.
    Finlay JL; Trigg ME; Link MP; Frierdich S
    Med Pediatr Oncol; 1989; 17(1):29-38. PubMed ID: 2913472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
    Rodriguez V; Cabanillas F; Burgess MA; McKelvey EM; Valdivieso M; Bodey GP; Freireich EJ
    Blood; 1977 Mar; 49(3):325-33. PubMed ID: 65189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N
    Ann Oncol; 2007 Jan; 18(1):149-157. PubMed ID: 17018708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
    Tomita N; Takasaki H; Ishiyama Y; Kishimoto K; Ishibashi D; Koyama S; Ishii Y; Takahashi H; Numata A; Watanabe R; Tachibana T; Ohshima R; Hagihara M; Hashimoto C; Takemura S; Taguchi J; Fujimaki K; Sakai R; Motomura S; Ishigatsubo Y
    Leuk Lymphoma; 2015 Mar; 56(3):725-9. PubMed ID: 24913502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma in adults: results of a pilot protocol.
    Coleman CN; Cohen JR; Burke JS; Rosenberg SA
    Blood; 1981 Apr; 57(4):679-84. PubMed ID: 6970598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prognosis for patients with mediastinal lymphoblastic lymphoma.
    Weinstein HJ; Vance ZB; Jaffe N; Buell D; Cassady JR; Nathan DG
    Blood; 1979 Apr; 53(4):687-94. PubMed ID: 581853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
    Abramson JS; Hellmann M; Barnes JA; Hammerman P; Toomey C; Takvorian T; Muzikansky A; Hochberg EP
    Cancer; 2010 Sep; 116(18):4283-90. PubMed ID: 20564149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis.
    Omura GA; Moffitt S; Vogler WR; Salter MM
    Blood; 1980 Feb; 55(2):199-204. PubMed ID: 6928104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: a Southwest Oncology Group study.
    Shaw MT; Raab SO
    Med Pediatr Oncol; 1977; 3(3):261-6. PubMed ID: 284167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma.
    Weinstein HJ; Cassady JR; Levey R
    J Clin Oncol; 1983 Sep; 1(9):537-41. PubMed ID: 6689428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of 2 therapeutic protocols in children with acute lymphoblastic leukemia of usual risk. Experience at the 20th of November National Medical Center].
    López-Hernández MA; de Diego Flores-Chapa J; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
    Gac Med Mex; 1998; 134(2):145-51. PubMed ID: 9618993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.